Ahmad Al-Abdouh1, Mohammed Mhanna2, Mohammad As Sayaideh3, Mahmoud Barbarawi4, Waiel Abusnina5, Ahmad Jabri6, Hossam Alzu'bi7, Anan Abu Rmilah7, Ikram-Ul Haq7, Ashish Kumar8, Taha Ahmed9, Erin D Michos10, Gurukripa N Kowlgi11, Abhishek Deshmukh11. 1. Division of Hospital Medicine, University of Kentucky, Lexington, KY, 40536, USA. ahmad_alabdouh@yahoo.com. 2. Department of Medicine, University of Toledo, Toledo, OH, USA. 3. Department of Medicine, University of Florida, Gainesville, FL, USA. 4. Department of Cardiology, University of Connecticut, Farmington, CT, USA. 5. Department of Cardiology, Creighton University School of Medicine, Omaha, NE, USA. 6. Department of Cardiology, Case Western Reserve University/MetroHealth Medical Center, Cleveland, OH, USA. 7. Department of Medicine, Mayo Clinic, Rochester, MN, USA. 8. Department of Internal Medicine, Cleveland Clinic Akron General, Akron, OH, USA. 9. Division of Hospital Medicine, University of Kentucky, Lexington, KY, 40536, USA. 10. Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 11. Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
Abstract
PURPOSE OF REVIEW: To evaluate remote monitoring using implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) devices as an adjunctive tool to the traditional care of patients with heart failure (HF). RECENT FINDINGS: We included 11 trials encompassing 5965 patients. Absolute risk difference (ARD) with 95% credible interval (CrI) was estimated. Pooled (posterior) risk difference was computed using Bayesian hierarchical methods. The ARD for mortality was centered at - 0.01 (95% CrI: - 0.03; 0.01, Tau: 0.02), with an 82% probability of ARD of ICD/CRT-D remote monitoring with respect to control being less than 0. The ARD for cardiovascular mortality was centered at - 0.03 (95% CrI: - 0.11; 0.05, Tau: 0.10), with an 84% probability of ARD of ICD/CRT-D remote monitoring with respect to control being less than 0. ICD/CRT-D remote monitoring in patients with HF is associated with a higher probability of reduced all-cause and cardiovascular mortality compared with standard care alone.
PURPOSE OF REVIEW: To evaluate remote monitoring using implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) devices as an adjunctive tool to the traditional care of patients with heart failure (HF). RECENT FINDINGS: We included 11 trials encompassing 5965 patients. Absolute risk difference (ARD) with 95% credible interval (CrI) was estimated. Pooled (posterior) risk difference was computed using Bayesian hierarchical methods. The ARD for mortality was centered at - 0.01 (95% CrI: - 0.03; 0.01, Tau: 0.02), with an 82% probability of ARD of ICD/CRT-D remote monitoring with respect to control being less than 0. The ARD for cardiovascular mortality was centered at - 0.03 (95% CrI: - 0.11; 0.05, Tau: 0.10), with an 84% probability of ARD of ICD/CRT-D remote monitoring with respect to control being less than 0. ICD/CRT-D remote monitoring in patients with HF is associated with a higher probability of reduced all-cause and cardiovascular mortality compared with standard care alone.
Authors: Salim S Virani; Alvaro Alonso; Emelia J Benjamin; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Francesca N Delling; Luc Djousse; Mitchell S V Elkind; Jane F Ferguson; Myriam Fornage; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Tak W Kwan; Daniel T Lackland; Tené T Lewis; Judith H Lichtman; Chris T Longenecker; Matthew Shane Loop; Pamela L Lutsey; Seth S Martin; Kunihiro Matsushita; Andrew E Moran; Michael E Mussolino; Amanda Marma Perak; Wayne D Rosamond; Gregory A Roth; Uchechukwu K A Sampson; Gary M Satou; Emily B Schroeder; Svati H Shah; Christina M Shay; Nicole L Spartano; Andrew Stokes; David L Tirschwell; Lisa B VanWagner; Connie W Tsao Journal: Circulation Date: 2020-01-29 Impact factor: 29.690
Authors: Michael K Ong; Patrick S Romano; Sarah Edgington; Harriet U Aronow; Andrew D Auerbach; Jeanne T Black; Teresa De Marco; Jose J Escarce; Lorraine S Evangelista; Barbara Hanna; Theodore G Ganiats; Barry H Greenberg; Sheldon Greenfield; Sherrie H Kaplan; Asher Kimchi; Honghu Liu; Dawn Lombardo; Carol M Mangione; Bahman Sadeghi; Banafsheh Sadeghi; Majid Sarrafzadeh; Kathleen Tong; Gregg C Fonarow Journal: JAMA Intern Med Date: 2016-03 Impact factor: 21.873
Authors: C Sardu; M Santamaria; M R Rizzo; M Barbieri; M di Marino; G Paolisso; G Santulli; R Marfella Journal: Int J Clin Pract Date: 2016-06-13 Impact factor: 2.503
Authors: Claudius Hansen; Christian Loges; Karlheinz Seidl; Frank Eberhardt; Herbert Tröster; Krum Petrov; Gerian Grönefeld; Peter Bramlage; Frank Birkenhauer; Christian Weiss Journal: BMC Cardiovasc Disord Date: 2018-06-28 Impact factor: 2.298